DCF — NORWALK HOSPITAL
Enterprise Value: $-891.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-891.5M
Enterprise Value
$-274.9M
PV of Cash Flows
$-616.6M
PV of Terminal Value
$-993.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $344.9M | $-59.4M | -17.0% | $-74.0M | $-67.3M |
| Year 2 | $355.3M | $-57.7M | -16.0% | $-72.7M | $-60.1M |
| Year 3 | $365.9M | $-55.7M | -15.0% | $-71.2M | $-53.5M |
| Year 4 | $376.9M | $-55.5M | -15.0% | $-71.5M | $-48.8M |
| Year 5 | $388.2M | $-56.2M | -14.0% | $-72.7M | $-45.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-891.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$334.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.17734278812956042
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5